The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Tumor Ablation Therapy Devices Market Expected To Reach Based On Its 2026 Value?
The tumor ablation therapy devices market has experienced swift expansion recently. This market is projected to expand from $0.82 billion in 2025 to $0.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. The historical growth in this sector is attributable to increasing cancer incidence rates, the expansion of oncology treatment centers, rising adoption of minimally invasive therapies, the availability of advanced imaging technologies, and a growing preference for organ-preserving treatments.
The tumor ablation therapy devices market is projected to experience swift expansion in the coming years. This market is anticipated to reach $1.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.2%. This growth during the forecast period is fueled by several factors, including greater financial commitments to precision oncology, a surge in demand for outpatient cancer therapies, the broadening scope of sophisticated ablation technologies, increased incorporation of imaging with therapy systems, and a heightened emphasis on individualized cancer care. Key trends foreseen for this period encompass a rise in the uptake of minimally invasive tumor ablation methods, increasing utilization of image-guided ablation systems, a growing need for ablation technologies tailored to specific organs, the spread of percutaneous treatment strategies, and a stronger concentration on precision oncology.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The Tumor Ablation Therapy Devices Market Forward?
The expanding occurrence of cancer serves as a primary impetus for the expansion of the tumor ablation therapy devices market. Globally, cancer is recognized as the second leading cause of mortality, accounting for approximately 1 in 6 deaths. This rise in cancer cases is largely propelled by aging populations, given that older individuals face an elevated risk of developing diverse cancer types throughout their lives. Tumor ablation, a minimally invasive technique, is extensively employed for treating tumors in the lungs, liver, kidneys, and bones. For example, data from 2023, provided by the American Cancer Society Inc., a non-profit health organization based in the US, projects 1,958,310 new cancer diagnoses in the US, indicating an increase from over 1,918,030 new cases reported in 2022. This procedure offers an effective solution for patients for whom chemotherapy or radiotherapy have been unsuccessful, thereby contributing to the growth of the tumor ablation therapy devices market.
What Are The Different Segment Types In The Tumor Ablation Therapy Devices Market Segment Breakdown?
The tumor ablation therapy devices market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
Which Trends Are Impacting The Progress Of The Tumor Ablation Therapy Devices Market?
Key companies within the tumor ablation therapy devices market are prioritizing the development of minimally invasive therapies to establish a competitive edge. Minimally invasive therapy is employed for tumor ablation, providing accurate and effective treatment with minimal impact on surrounding tissues. For example, in August 2023, the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Vanquish minimally invasive water vapor ablation therapy from Francis Medical Inc., a US-based firm offering minimally invasive treatment solutions for prostate, kidney, and bladder cancer. This initiative is designed to accelerate the device’s development and streamline its regulatory review, potentially allowing patients quicker access. Vanquish harnesses the thermal energy from a small quantity of sterile water to deliver precise treatments to cancerous tissue through a simple transurethral procedure. The treatment is engineered to eliminate cancer cells while preserving nearby structures, thereby reducing the risk of severe side effects often associated with alternative prostate cancer therapies.
Who Are The Well-Known Companies In The Tumor Ablation Therapy Devices Market?
Major companies operating in the tumor ablation therapy devices market are Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Bovie Medical Corporation,
Get The Full Tumor Ablation Therapy Devices Market Report:
Which Region Is The Top Contributor To The Tumor Ablation Therapy Devices Market By Share?
North America was the largest region in the tumor ablation therapy devices market in 2025. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Tumor Ablation Therapy Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Tumor Ablation Therapy Devices Market 2026, By The Business Research Company
Tumor Ablation Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report
Oncology Ablation Market Report 2026
https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report
Ablation Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ablation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model